Reproductive rights groups sue FDA over EC

Article

The Center for Reproductive Rights filed a lawsuit against the acting commissioner of the Food and Drug Administration in January for failing to approve an emergency contraceptive (EC) for over-the-counter access.

The Center for Reproductive Rights filed a lawsuit against the acting commissioner of the Food and Drug Administration in January for failing to approve an emergency contraceptive (EC) for over-the-counter access. The lawsuit was filed hours after the FDA decided it would delay a decision to make the EC product Plan B available to women aged 16 and older without a prescription.

Last year, the FDA rejected a similar request to make Plan B available without a prescription to women of all ages. The FDA cited a lack of information on whether the EC could be taken safely by women under the age of 16 and whether it would promote risky sexual behavior.

In response, Plan B's manufacturer modified its application for over-the-counter status by limiting access to those aged 16 or older. The FDA responded by delaying its decision.

Recent Videos
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
How the cobas liat assay panels improve STI detection | Image Credit: labqualityconfab.
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Henri M. Rosenberg, MD
Medical experts personalize contraceptive options for complex cases | Image Credit: findcare.ahn.org
Study explores the limits of neighborhood data in predicting preterm birth | Image Credit: linkedin.com
Barbed suture reduces blood loss in hysterectomy | Image Credit: linkedin.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.